can bpc 157 help knee pain BPC-157 For Pain: Early Reported Outcomes A report on intra-articular BPC-157 for knee described high rates of improvement: ~92% with BPC-157 alone, ~75% when combined with thymosin beta-4, and overall BPC-157 For Knee Pain: Early

Microdosing and customization Microdosing refers to using smaller or fractional doses, which are lower than therapeutic doses

Half-life: AOD-9604 approximately 4 minutes (preclinical estimate)

While no studies have specifically measured scar quality as a primary outcome, BPC-157s effects on collagen organization, granulation tissue maturation, inflammation modulation, and re-epithelialization speed all favor improved cosmetic outcomes compared to unsupported healing

In a small Phase III trial in neurotrophic keratopathy (a condition where the cornea loses sensation and fails to heal), complete healing at four weeks occurred in 6 of 10 patients on thymosin 4 eye drops versus 1 of 8 on placebo [3]